Laurent Bélec Selected Research

Laurent Bélec Research Topics

Disease

17	Infections 01/2022 - 01/2002
11	COVID-19 06/2022 - 01/2020
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 01/2019
4	Virus Diseases (Viral Diseases) 01/2021 - 01/2005
4	Acquired Immunodeficiency Syndrome (AIDS) 05/2020 - 01/2002
3	Papillomavirus Infections 10/2023 - 01/2020
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018 - 09/2002
3	HIV Infections (HIV Infection) 07/2011 - 03/2004
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2021 - 11/2005
2	Hepatitis C 05/2018 - 01/2018
2	Herpes Genitalis (Genital Herpes) 05/2014 - 07/2009
2	Neoplasms (Cancer) 11/2009 - 12/2007
2	HIV Seropositivity 05/2003 - 09/2002
1	Communicable Diseases (Infectious Diseases) 01/2022
1	COVID-19 rebound 01/2022
1	Fever (Fevers) 01/2022
1	Human Influenza (Influenza) 08/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Cryptococcal Meningitis 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Herpes Zoster 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Oropharyngeal Neoplasms 01/2020
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2020
1	Disease Progression 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Persistent Infection 01/2018
1	Tetanus 01/2017
1	Whooping Cough (Pertussis) 01/2017
1	Poliomyelitis (Polio) 01/2017
1	Diphtheria 01/2017
1	Syphilis 12/2013
1	Diabetes Complications 05/2011
1	Hyperglycemia 05/2011
1	Sarcoma (Soft Tissue Sarcoma) 11/2009
1	Neuroblastoma 11/2009
1	Glioblastoma (Glioblastoma Multiforme) 11/2009
1	Ulcer 07/2009
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2005
1	Herpes Simplex 06/2003
1	Progressive Multifocal Leukoencephalopathy 01/2002

Drug/Important Bio-Agent (IBA)

13	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2002
7	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2003
7	AntibodiesIBA 05/2018 - 05/2003
5	VaccinesIBA 10/2023 - 04/2005
5	Immunoglobulin G (IgG)IBA 01/2021 - 01/2020
4	AntigensIBA 06/2022 - 03/2004
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 01/2018
3	Nucleocapsid ProteinsIBA 06/2022 - 05/2021
3	Proteins (Proteins, Gene)FDA Link 06/2022 - 12/2007
3	Immunoglobulin M (IgM)IBA 01/2021 - 01/2020
2	Nucleic AcidsIBA 11/2020 - 01/2005
2	Anti-Infective Agents (Microbicides)IBA 07/2011 - 06/2010
2	Complement System Proteins (Complement)IBA 06/2010 - 01/2007
1	Ribonuclease P (RNase P)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	CytokinesIBA 11/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	NucleotidesIBA 01/2019
1	Surface Antigens (Surface Antigen)IBA 05/2018
1	Tramadol (K315)FDA LinkGeneric 12/2017
1	calcium phosphateIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 05/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2011
1	Advanced Glycation End ProductsIBA 05/2011
1	ProdrugsIBA 11/2009
1	nicotinate phosphoribosyltransferaseIBA 11/2009
1	1- (2- (2- (2- (2- methoxyethoxy)ethoxy)ethoxy)ethoxycarbonyloxymethyl)- 4- (N'- cyano- N''- (6- (4- chlorophenoxy)hexyl)- N- guanidino)pyridiniumIBA 11/2009
1	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 11/2009
1	NAD (NADH)IBA 11/2009
1	Messenger RNA (mRNA)IBA 11/2009
1	Acyclovir (Aciclovir)FDA LinkGeneric 07/2009
1	Monoterpenes (Monoterpenoids)IBA 06/2008
1	ZincIBA 06/2008
1	Chemokine CCL5IBA 01/2007
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2007
1	Combined VaccinesIBA 11/2005
1	Indicators and Reagents (Reagents)IBA 04/2005
1	dermaseptinIBA 04/2005
1	Local Anti-Infective Agents (Antiseptics)IBA 04/2005
1	Antimicrobial PeptidesIBA 04/2005
1	Peptides (Polypeptides)IBA 02/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2004
1	Codon (Codons)IBA 02/2004

Therapy/Procedure

6	Therapeutics 01/2022 - 07/2009
1	Self-Testing 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2020
1	Condoms (Condom) 09/2002